Perioperative acute kidney injury

Stacey Calvert, Andrew Shaw, Stacey Calvert, Andrew Shaw

Abstract

Acute kidney injury (AKI) is a serious complication in the perioperative period, and is consistently associated with increased rates of mortality and morbidity. Two major consensus definitions have been developed in the last decade that allow for easier comparison of trial evidence. Risk factors have been identified in both cardiac and general surgery and there is an evolving role for novel biomarkers. Despite this, there has been no real change in outcomes and the mainstay of treatment remains preventive with no clear evidence supporting any therapeutic intervention as yet. This review focuses on definition, risk factors, the emerging role of biomarkers and subsequent management of AKI in the perioperative period, taking into account new and emerging strategies.

Keywords: Acute kidney injury; Biomarkers; Perioperative; Pharmacological interventions; Risk stratification.

References

    1. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C. Acute renal failure in critically ill paitents: a multinational, multicenter study. JAMA. 2005;1:813–818. doi: 10.1001/jama.294.7.813.
    1. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;1:343–348. doi: 10.1016/S0002-9343(98)00058-8.
    1. Thaker CV, Kharat V, Blanck S, Leaonard AC. Acute kidney injury after gastric bypass surgery. Clin J Am Soc Nephrol. 2007;1:426–430. doi: 10.2215/CJN.03961106.
    1. Loef BG, Epema AH, Smilde TD, Henning RH, Ebels T, Navis G, Stegeman CA. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol. 2005;1:195–200.
    1. Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M. Minimal changes of serum creatinine predict poor prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;1:1597–1605. doi: 10.1097/01.ASN.0000130340.93930.DD.
    1. Ishani A, Nelson D, Clothier B, Schult T, Nugent S, Greer N, Slinin Y, Ensrud KE. The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch Intern Med. 2011;1:226–233. doi: 10.1001/archinternmed.2010.514.
    1. Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon AJ, Bihorac A. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009;1:2444–2453. doi: 10.1161/CIRCULATIONAHA.108.800011.
    1. Bihorac A, Yavas S, Subbiah S, Hobson CE, Schold JD, Gabrielli A, Layon AJ, Segal MS. Long term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg. 2009;1:851–858. doi: 10.1097/SLA.0b013e3181a40a0b.
    1. Lafrance JP, Miller DR. Acute kidney injury associates with increased long-term mortality. J Am Soc Nephrol. 2010;1:345–352. doi: 10.1681/ASN.2009060636.
    1. Palevskky PM. Epidemiology of acute renal failure: the tip of the Iceberg. Clin J Am Soc Nephrol. 2006;1:6–7.
    1. Mehta RL, Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, Paganini EP, Chertow GM. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int. 2004;1:1613–1621. doi: 10.1111/j.1523-1755.2004.00927.x.
    1. Mehta RL, Kellum JA, Shah AV, Molitoris BA, Ronco C, Warnock DG, Levin A. the Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcome in acute kidney injury. Crit Care. 2007;1:R31. doi: 10.1186/cc5713.
    1. Metnitz PG, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, Le Gall JR, Druml W. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med. 2002;1:2051–2058. doi: 10.1097/00003246-200209000-00016.
    1. Liano F, Junco E, Pascual J, Madero R, Verde E. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int. 1998;1:S16–S24.
    1. Druml W. Long term prognosis of patients with acute renal failure: is intensive care worth it? Intensive Care Med. 2005;1:1145–1147. doi: 10.1007/s00134-005-2682-5.
    1. Mehta RL, Chertow GM. Acute renal failure definitions and classification: time for change? J Am Soc Nephrol. 2003;1:2178–2187. doi: 10.1097/01.ASN.0000079042.13465.1A.
    1. Carmichael P, Carmichael AR. Acute renal failure in the surgical setting. ANZ J Surg. 2003;1:144–153. doi: 10.1046/j.1445-2197.2003.02640.x.
    1. Shusterman N, Strom BL, Murray TG, Morrison G, West SL, Maislin G. Risk factors and outcome of hospital acquired acute renal failure. Clinical epidemiologic study. Am J Med. 1987;1:65–71.
    1. Liangos O, Wald R, O’Bell JW, Price L, Pereira BJ, Jabor BL. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol. 2006;1:43–51.
    1. Kheterpal S, Tremper KK, Englesbe MJ, O’Reilly M, Shanks AM, Fetterman DM, Rosenberg AL, Swartz RD. Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology. 2007;1:892–902. doi: 10.1097/01.anes.0000290588.29668.38.
    1. Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ. Incidence and mortality of acute renal failure in medicare beneficiaries, 1992–2001. J Am Soc Nephrol. 2006;1:1135–1142. doi: 10.1681/ASN.2005060668.
    1. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;1:3365–3370. doi: 10.1681/ASN.2004090740.
    1. Kheterpal S, Tremper KK, Heung M, Rosenberg AL, Englesbe M, Shanks AM, Campbell DA. Development and validation of an acute kidney injury risk index for patients undergoing general surgery. Anesthesiology. 2009;1:505–515. doi: 10.1097/ALN.0b013e3181979440.
    1. Chertow GM, Lazarus M, Christiansen CL, Cook F, Hammermeister KE, Grover F, Daley J. Preoperative renal risk stratification. Circulation. 1997;1:878–884. doi: 10.1161/01.CIR.95.4.878.
    1. Kolhe NV, Stevens PE, Crowe AV, Lipkin GW, Harrison DA. Case mix, outcome and activity for patients with severe acute kidney injury during the first 24 hours after admission to an adult general critical care unit: application of predictive models from a secondary analysis of the ICNARC Case Mix Programme database. Crit Care. 2008;1(Suppl 1):S2. doi: 10.1186/cc7003.
    1. Bellomo R, Kellum JA, Ronco C. Defining acute renal failure: physiological principles. Intensive Care Med. 2006;1:33–37.
    1. Bellomo R, Kellum JA, Ronco C. Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med. 2009;1:409–413.
    1. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;1:R204–R212. doi: 10.1186/cc2872.
    1. Bagshaw SM, George C, Bellomo R. A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2008;1:1569–1574. doi: 10.1093/ndt/gfn009.
    1. Abosaif NY, Tolba YA, Heap M, Russel J, El Nahas AM. The outcome of acute renal failure in the intensive care unit according to RIFLE: model application, sensitivity, and predictability. Am J Kidney Dis. 2005;1:1038–1048. doi: 10.1053/j.ajkd.2005.08.033.
    1. Hoste EA, Clermont G, Kerston A, Ventataraman R, Angus DC, De Bacquer D, Kellum JA. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006;1:R73. doi: 10.1186/cc4915.
    1. Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettila V. Acute renal failure after cardiac surgery: evaluation of the RIFLE criteria. Ann Thorac Surg. 2006;1:542–546. doi: 10.1016/j.athoracsur.2005.07.047.
    1. Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C. An assessment of RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med. 2006;1:1913–1917. doi: 10.1097/01.CCM.0000224227.70642.4F.
    1. Ostermann M, Chang RW. Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med. 2007;1:1837–1845. doi: 10.1097/01.CCM.0000277041.13090.0A.
    1. O’Riordan A, Wong V, McQuillan R, McCormick PA, Hegarty JE, Watson AJ. Acute renal disease, as defined by the RIFLE criteria, post-liver transplantation. Am J Transplant. 2007;1:168–176. doi: 10.1111/j.1600-6143.2006.01602.x.
    1. Disease K. Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Kidney Int Suppl. 2012;1:1–138.
    1. Selby NM, Crowley L, Fluck RJ, McIntyre CW, Monaghan J, Lawson H, Kohle NV. Use of electronic results reporting to diagnose and monitor AKI in hospitalized patients. Clin J Am Soc Nephrol. 2012;1:533–540. doi: 10.2215/CJN.08970911.
    1. Coca SG, Yalavarthy R, Concato J, Parikh CR. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 2007;1:1008–1016.
    1. Dent CL, Ma Q, Dastrala S, Bennett M, Mitsnefes MM, Barasch J, Devarajan P. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care. 2007;1:R127. doi: 10.1186/cc6192.
    1. Herget-Rosenthal S, Marggraf G, Husing J, Goring F, Petruck F, Janssen O, Philipp T, Kribben A. Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004;1:1115–1122. doi: 10.1111/j.1523-1755.2004.00861.x.
    1. American Society of Nephrology Renal Research Report. J Am Soc Nephrol. 2005;1:1886–1890.
    1. Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol. 2005;1:162–168.
    1. Fortescue EB, Bates DW, Chertow GM. Predicting acute renal failure after coronary bypass surgery: cross-validation of two risk stratification algorithms. Kidney Int. 2000;1:2594–2602. doi: 10.1046/j.1523-1755.2000.00119.x.
    1. Thakar CV, Liangos O, Yared J-P, Nelson DA, Hariachar S, Paganini EP. Validation and re-definition of a risk stratification algorithm. Hemodial Int. 2003;1:143–147. doi: 10.1046/j.1492-7535.2003.00029.x.
    1. Eriksen BO, Hoff KRS, Solberg S. Prediction of acute renal failure after cardiac surgery: retrospective cross-validation of a clinical algorithm. Nephrol Dial Transplant. 2003;1:77–81. doi: 10.1093/ndt/18.1.77.
    1. Brienza N, Giglio MT, Marucci M, Fiore T. Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study. Crit Care Med. 2009;1:2079–2090. doi: 10.1097/CCM.0b013e3181a00a43.
    1. Candela-Toha A, Elias-Martin E, Abraira V, Tenorio MT, Parise D, de Pablo A, Centella T, Liano F. Predicting acute renal failure after cardiac surgery: external validation of two new clinical scores. Clin J Am Soc Neprhol. 2008;1:1260–1265. doi: 10.2215/CJN.00560208.
    1. Mayeux R. Biomarkers: potential uses and limitations. NeuroRx. 2004;1:182–188. doi: 10.1602/neurorx.1.2.182.
    1. Ray P, Yannick M, Riou B, Houle T. Statistical evaluation of a biomarker. Anesthesiology. 2010;1:1023–1040. doi: 10.1097/ALN.0b013e3181d47604.
    1. Waiker SS, Betensky RA, Bonventre JV. Creatinine as the gold standard for kidney injury biomarker studies? Nephrol Dial Transplant. 2009;1:3263–3265. doi: 10.1093/ndt/gfp428.
    1. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal failure after cardiac surgery. Lancet. 2005;1:1231–1238. doi: 10.1016/S0140-6736(05)74811-X.
    1. Wagener G, Gubitosa G, Wang S, Borregaard N, Kim M, Lee HT. Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery. Am J Kidney Dis. 2008;1:425–433. doi: 10.1053/j.ajkd.2008.05.018.
    1. Hirch R, Dent C, Pfriem H, Allen J, Beekman RH, Ma Q, Bennett M, Mitsnefes M, Devarajan P. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol. 2007;1:2089–2095. doi: 10.1007/s00467-007-0601-4.
    1. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003;1:2534–2543. doi: 10.1097/01.ASN.0000088027.54400.C6.
    1. Perry TE, Muehlschlegel JD, Liu KY, Fax AA, Collard CD, Shernan SK. Body SC for the CABG Genomics Investigators. Plasma neutrophil gelatinase-associated lipocalin and acute postoperative kidney injury in adult cardiac surgical patients. Anesth Analg. 2010;1:1541–1547. doi: 10.1213/ANE.0b013e3181da938e.
    1. Koyner JL, Vaidya VS, Bennett MR, Ma Q, Worcester E, Akhtar SA, Raman J, Jeevanandam V, O’Connor MF, Devarajan P, Bonventre JV, Murray PT. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol. 2010;1:2154–2165. doi: 10.2215/CJN.00740110.
    1. McIlroy DR, Wagener G, Lee TH. Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol. 2010;1:211–219. doi: 10.2215/CJN.04240609.
    1. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;1:237–244. doi: 10.1046/j.1523-1755.2002.00433.x.
    1. Han WK, Waikar SS, Johnson A, Betensky RA, Dent CL, Deverajan P, Bonventre JV. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 2008;1:863–869. doi: 10.1038/sj.ki.5002715.
    1. Liangos O, Perianayagam MC, Vaidya VS, Han WK, Wald R, Tighiouart H, MacKinnon RW, Li L, Balakrishnan VS, Pereira BJG, Bonventre JV, Jaber BL. Urinary N-acetyl-β-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol. 2007;1:904–912. doi: 10.1681/ASN.2006030221.
    1. Parikh CR, Mishra J, Thiessen-Philbrook H, Dursun B, Ma Q, Kelly C, Dent C, Deverajan P, Edelstein CL. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2006;1:199–203. doi: 10.1038/sj.ki.5001527.
    1. Parikh CR, Jani A, Melnikov VY, Faubel S, Edelstein CL. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis. 2004;1:405–414. doi: 10.1053/j.ajkd.2003.10.040.
    1. Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol. 2005;1:3046–3052. doi: 10.1681/ASN.2005030236.
    1. Washburn KK, Zappitelli M, Arikan AA, Lofis L, Yalavarthy R, Parikh CR, Edelstein CL, Goldstein SL. Urinary interleukin-18 is an acute kidney injury biomarker in critically ill children. Nephrol Dial Transplant. 2008;1:566–572.
    1. Parikh CR, Jani A, Mishra J, Ma Q, Kelly C, Barasch J, Edelsteinn CL, Deverajan P. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant. 2006;1:1639–1645. doi: 10.1111/j.1600-6143.2006.01352.x.
    1. Wald R, Liangos O, Perianayagam MC, Kolyada A, Herget-Rosenthal S, Mazer CD, Jaber BL. Plasma cystatin C and acute kidney injury after cardiopulmonary bypass. Clin J Am Soc Nephrol. 2010;1:1373–1379. doi: 10.2215/CJN.06350909.
    1. Koyner JL, Bennet MR, Worcester EM, Ma Q, Raman J, Jeevanadam V, Kasza KE, O’Connor MF, Konczal DJ, Trevino S, Devarajan P, Murray PT. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008;1:1059–1069. doi: 10.1038/ki.2008.341.
    1. Dharnidharka VR, Kown C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Disease. 2002;1:221–226. doi: 10.1053/ajkd.2002.34487.
    1. Redfors B, Bragadottir G, Sellgren J, Sward K, Rickstein SE. Acute renal failure is NOT an “acute renal success” – a clinical study on the renal oxygen supply/demand relationship in acute kidney injury. Crit Care Med. 2010;1:1695–1701. doi: 10.1097/CCM.0b013e3181e61911.
    1. Brezis M, Rosen S, Silva P, Epstein FH. Renal ischemia: a new perspective. Kidney Int. 1984;1:375–383. doi: 10.1038/ki.1984.185.
    1. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol. 2003;1:2199–2210. doi: 10.1097/01.ASN.0000079785.13922.F6.
    1. Callister MEJ, Evans TW. Pulmonary vs extra-pulmonary ARDS: different disease or just a useful concept. Curr Opin Crit Care. 2002;1:21–25. doi: 10.1097/00075198-200202000-00004.
    1. Okusa MD. The inflammatory cascade in acute ischemic renal failure. Nephron. 2002;1:133–138. doi: 10.1159/000049032.
    1. Wan L, Bellomo R, Giantomasso DD, Ronco C. The pathogenesis of septic acute renal failure. Curr Opin Crit Care. 2003;1:496–502. doi: 10.1097/00075198-200312000-00006.
    1. Fink MP. Cytopathic hypoxia. Is oxygen use impaired in sepsis as a result of an acquired intrinsic derangement in cellular respiration? Crit Care Clin. 2002;1:165–175. doi: 10.1016/S0749-0704(03)00071-X.
    1. Rahbari NN, Zimmermann JB, Schmidt T, Koch M, Weigand MA, Weitz J. Meta-analysis of standard, restrictive and supplemental fluid administration in colorectal surgery. Br J Surg. 2009;1:331–341. doi: 10.1002/bjs.6552.
    1. Prowle JR, Echeverri JE, Ligabo EV, Ronco C, Bellomo R. Fluid balance and acute kidney injury. Nat Rev Nephrol. 2010;1:107–115. doi: 10.1038/nrneph.2009.213.
    1. Sugrue M, Jones F, Deane SAG, Bauman A, Hillman K. Intra-abdominal hypertension is an independent cause of post-operative renal impairment. Arch Surg. 1999;1:1082–1085. doi: 10.1001/archsurg.134.10.1082.
    1. McNelis J, Marini CP, Jurkiwicz A, Fields S, Caplin D, Stein D, Ritter G, Nathan I, Simms H. Predictive factors associated with the development of abdominal compartment syndrome in the surgical intensive care unit. Arch Surg. 2002;1:133–136. doi: 10.1001/archsurg.137.2.133.
    1. Joannidis M, Druml W, Forni LG, Groeneveld ABJ, Honore P, Oudemas-van Straated HM, Ronco C, Schetz MRC, Wottiez AJ. Prevention of acute kidney injury and protection of renal function in ITU. Intensive Care Med. 2010;1:392–411. doi: 10.1007/s00134-009-1678-y.
    1. Chappell D, Matthias J, Hofmann-Kiefer K, Conzen P, Rehm M. A rational approach to perioperative fluid management. Anesthesiology. 2008;1:723–740. doi: 10.1097/ALN.0b013e3181863117.
    1. Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett EDl. Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomized controlled trial. Crit Care. 2005;1:R687–R693. doi: 10.1186/cc3887.
    1. Shoemaker WC, Appel PL, Kram HB. Hemodynamic and oxygen transport responses in survivors and non-survivors of high-risk surgery. Crit Care Med. 1993;1:977–990. doi: 10.1097/00003246-199307000-00010.
    1. Rhodes A, Cecconi M, Hamilton M, Poloniecki J, Woods J, Boyd O, Bennett D, Grounds RM. Goal-directed therapy in high-risk surgical patients: a 15-year follow-up study. Intensive Care Med. 2010;1:1327–1332. doi: 10.1007/s00134-010-1869-6.
    1. Haase M, Haase-Fielitz A, Bellomo R, Devararjan P, Story D, Matalanis G, Reade MC, Bagshaw SM, Seevanayagam N, Seevanayagam S, Doolan L, Buxton B, Dragun D. Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med. 2009;1:39–47. doi: 10.1097/CCM.0b013e318193216f.
    1. Zacharias M, Conlon NP, Herbison GP, Sivalingam P, Hovhannisyan K. Interventions for preventing renal function in the perioperative period. Cochrane Database Syst Rev. 2008;1(4) CD003590.
    1. Medicines and Healthcare Products Regulatory Agency: Non-steroidal anti-inflammatory drugs: reminder on renal failure and impairment. .
    1. McCullough PA, Soman SS. Contrast induced nephropathy. Crit Care Clin. 2005;1:261–280. doi: 10.1016/j.ccc.2004.12.003.
    1. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. NEPHRIC Study Investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;1:491–499. doi: 10.1056/NEJMoa021833.
    1. Brigouri C, Colombo A, Violante A, Balastrieri P, Manganelli F, Paolo Elia P, Golia B, Lepore S, Riviezzo G, Scarpato P, Focaccio A, Librera M, Bonizzoni E, Ricciardelli B. Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J. 2004;1:206–211. doi: 10.1016/j.ehj.2003.11.016.
    1. Habib RH, Zacharias A, Schwann TA. Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: implications on operative outcomes. Crit Care Med. 2005;1:1749–1756. doi: 10.1097/01.CCM.0000171531.06133.B0.
    1. Kartouki K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M, Dupuis JY, Fremes SE, Kent B, Laflamme C, Lamy A, Legare JF, Mazer CD, McCLuskey SA, Rubens FD, Sawchuk C, Beattie WS. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation. 2009;1:495–502. doi: 10.1161/CIRCULATIONAHA.108.786913.
    1. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;1:2544–2552. doi: 10.1161/CIRCULATIONAHA.107.698977.
    1. Kartouki K, Wijeysundera DN, Beattie WS. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation. 2008;1:478–484. doi: 10.1161/CIRCULATIONAHA.107.718353.
    1. Kartouki K, Wijeysundera DN, Yau TM, McCluskey SA, Chan CT, Wony PY, Beattie WS. Influence of erythrocyte transfusion on the risk of acute kidney injury after cardiac surgery differs in anemic and nonanemic patients. Anesthesiology. 2011;1:523–530. doi: 10.1097/ALN.0b013e318229a7e8.
    1. Song YR, Lee T, You SJ, Chin HJ, Chae DW, Lim C, Park KH, Han S, Kim JH, Na KY. Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass gratfing: a pilot study. Am J Nephrol. 2009;1:253–260. doi: 10.1159/000223229.
    1. Swaminathan M, Phillips-Bute BG, Conlon PJ, Smith PK, Newman MF, Stafford-Smith M. The association of lowest hematocrit during cardiopulmonary bypass surgery with acute renal failure after coronary artery bypass surgery. Ann Thorac Surg. 2003;1:784–792. doi: 10.1016/S0003-4975(03)00558-7.
    1. Karkouti K, Beattie WS, Wijeysundera DN, Rao V, Chan C, Dattilo KM, Djaiani G, Ivanon J, Karski J, David TE. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg. 2005;1:391–400. doi: 10.1016/j.jtcvs.2004.06.028.
    1. Society of Thoracic Surgeons Blood Conservation Guideline Task Force; Ferraris VA, Ferraris SP, Saha SP, Hessel EA, Haan CK, Royston BD, Bridges CR, Higgins RS, Despotis G, Brown JR. Society of Cardiovascular Anaesthesiologists Special Task Force on Blood Transfusion. Speiss BD, Shore-Lesserson L, Stafford-Smith M, Mazer CD, Bennett-Guerrero E, Hill E, Body S. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg. 2007;1:S27–S86. doi: 10.1016/j.athoracsur.2007.02.099.
    1. Vretzakis G, Kleitsaki A, Stamoulis K, Bareka M, Georgopoulou S, Karanikolas M, Giannoulas A. Intra-operative intravenous fluid restriction reduces perioperative red blood cell transfusion in elective cardiac surgery, especially in transfusion-prone patients: a prospective, randomized controlled trial. J Cardiothorac Surg. 2010;1:7. doi: 10.1186/1749-8090-5-7.
    1. Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000;1:97–104.
    1. Carcoana OV, Hines RL. Is renal dose dopamine protective or therapeutic? Yes. Crit Care Clin. 1996;1:677–685. doi: 10.1016/S0749-0704(05)70271-2.
    1. Kellum JA, Decker JM. Use of dopamine in acute renal failure: A meta-analysis. Crit Care Med. 2001;1:1526–1531. doi: 10.1097/00003246-200108000-00005.
    1. Landoni G, Biondi-Zoccai GG, Marino G, Bove T, Fochi O, Maj G, Calabro MG, Sheiban I, Tumlin JA, Ranucci M, Zangrillo A. Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis. J Cardiothorac Vasc Anesth. 2008;1:27–33. doi: 10.1053/j.jvca.2007.07.015.
    1. Ng MK, Tremmel J, Fitzgerald PJ, Fearon WF. Selective renal arterial infusion of fenoldopam for the prevention of contrast-induced nephropathy. J Interv Cardiol. 2006;1:75–79. doi: 10.1111/j.1540-8183.2006.00108.x.
    1. Carcoana OV, Mathew JP, David E, Byrne DW, Hayslett JP, Hines RL, Garwood S. Mannitol and dopamine in patients undergoing cardiopulmonary bypass: A randomized clinical trial. Anesth Analg. 2003;1:1222–1229.
    1. Sirivella S, Gielchinsky I, Parsonnet V. Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery. Ann Thorac Surg. 2000;1:501–506. doi: 10.1016/S0003-4975(99)01298-9.
    1. Van der Voort PHJ, Boerma EC, Koopmans M, Zandberg M, de Ruiter J, Gerritsen RT, Egbers PH, Kingma WP, Kuiper MA. Furosemide does not improve renal recovery after hemofiltration for acute renal failure: a double blind randomized controlled trial. Crit Care Med. 2009;1:533–538. doi: 10.1097/CCM.0b013e318195424d.
    1. Rigden SP, Dillon MJ, Kind PR, de Leval M, Stark J, Barratt TM. The beneficial effect of mannitol on postoperative renal function in children undergoing cardiopulmonary bypass surgery. Clin Nephrol. 1984;1:148–151.
    1. Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, Sweet RM, Genter FC, Kurnik BR, Conger JD, Sayegh MH. Anaritide in acute tubular necrosis: Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med. 1997;1:828–834. doi: 10.1056/NEJM199703203361203.
    1. Lewis J, Salem MM, Chertow GM, Weidberg LS, McGrew F, Marbury TC, Allgren RL. Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am J Kidney Dis. 2000;1:767–774. doi: 10.1053/ajkd.2000.17659.
    1. Rahman SN, Kim GE, Mathew AS, Goldberg CA, Allgren R, Schrier RW, Conger JD. Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int. 1994;1:1731–1738. doi: 10.1038/ki.1994.225.
    1. Sward K, Valsson F, Odencrants P, Samuelsson O, Ricksten SE. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med. 2004;1:1310–1315. doi: 10.1097/.
    1. Nigewaker SU, Navaneethan SD, Parikh CR, Hix JK. Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009;1:261–272. doi: 10.2215/CJN.03780808.
    1. Mentzer RM, Oz MC, Sladen RC, Graeve AH, Hebeler RF, Luber JM, Smedira NG. NAPA Investigators. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: The NAPA trial. J Am Coll Cardiol. 2007;1:716–726. doi: 10.1016/j.jacc.2006.10.048.
    1. Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA. 2005;1:1900–1905. doi: 10.1001/jama.293.15.1900.
    1. Bagshaw SM, Ghali A. Theophylline for prevention of contrast-induced nephrology. Arch Intern Med. 2005;1:1087–1093. doi: 10.1001/archinte.165.10.1087.
    1. Kramer BK, Preuner J, Ebenburger A, Kaiser M, Bergner U, Eilles C, Kammerl MC, Riegger GAJ, Birnbaum DE. Lack of renoprotective effect of theophylline during aortocoronary bypass surgery. Nephrol Dial Transplant. 2002;1:910–915. doi: 10.1093/ndt/17.5.910.
    1. Adabag AS, Ishani A, Bloomfoeld HE, Ngo AK, Wilt TJ. Efficacy of N-acetylcysteine in preventing renal injury after heart surgery: a systematic review of randomized trials. Eur Heart Journal. 2009;1:1910–1917. doi: 10.1093/eurheartj/ehp053.
    1. Nigwekar SU, Kandula P. N-acetylcysteine in cardiovascular-surgery-associated renal failure: a meta-analysis. Ann Thorac Surg. 2009;1:139–147. doi: 10.1016/j.athoracsur.2008.09.026.
    1. Van de Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;1:1359–1367. doi: 10.1056/NEJMoa011300.
    1. Lena D, Kalfon P, Preiser JC, Ichai C. Glycemic control in the Intensive Care Unit and during the postoperative period. Anesthesiology. 2011;1:438–444. doi: 10.1097/ALN.0b013e3182078843.
    1. Duncan AE, Abd-Elsayed A, Maheshwari A, Xu M, Soltesz E, Koch CG. Role of intraoperative and postoperative blood glucose concentrations in predicting outcomes after cardiac surgery. Anesthesiology. 2010;1:860–871. doi: 10.1097/ALN.0b013e3181d3d4b4.
    1. Durmaz I, Yagdi T, Calkavur T, Mahmudiv R, Apaydon AZ, Posacioglu H, Atay Y, Engin C. Prophylactic dialysis in patients with renal dysfunction undergoing on-pump coronary artery bypass surgery. Ann Thorac Surg. 2003;1:859–864. doi: 10.1016/S0003-4975(02)04635-0.
    1. Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, Trabattoni D, Fabiocchi F, Montorsi P, Bartorelli AL. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Eng J Med. 2003;1:1333–1340. doi: 10.1056/NEJMoa023204.
    1. Ostermann M, Chang R. Correlation between the AKI classification and outcome. Crit Care. 2008;1:R144. doi: 10.1186/cc7123.
    1. Granado RC, Mehta RL. Assessing and delivering dialysis dose in acute kidney injury. Semin Dial. 2011;1:157–163. doi: 10.1111/j.1525-139X.2011.00833.x.
    1. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet. 2000;1:26–30. doi: 10.1016/S0140-6736(00)02430-2.
    1. Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM. Standard versus high dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol. 2008;1:1233–1238. doi: 10.1681/ASN.2007111173.
    1. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuiness S, Myburgh J, Norton R, Scheinkestel C, Su S. Intensity of continuous renal replacement therapy in critically ill patients. N Engl J Med. 2009;1:1627–1638.
    1. Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;1:7–20.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe